Allen Institute Launches Brain Health Accelerator for Genetic Therapies

The Allen Institute launched the Brain Health accelerator in Seattle to develop genetic therapies targeting neurodegenerative diseases such as Alzheimer's and Huntington's disease. According to NPR, this effort represents a significant advancement in research aimed at treating brain disorders. The initiative focuses on creating new genetic approaches to combat these conditions and improve brain health outcomes.